A carregar...
Second-line treatment in renal cell carcinoma: clinical experience and decision making
Currently, conventional treatments for metastatic RCC (mRCC) include immune-based combination regimens and/or targeted therapies, the latter mainly acting on angiogenesis, a key element of the process of tumor growth and spread. Although these agents proved able to improve patients’ outcomes, drug r...
Na minha lista:
| Publicado no: | Ther Adv Urol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8216352/ https://ncbi.nlm.nih.gov/pubmed/34211586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17562872211022870 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|